All members of the Pulmonary, Critical Care and Sleep Medicine Division of the Icahn School of Medicine at Mount Sinai make research a priority in their work. Mount Sinai is committed to providing you access to the clinical trials that are turning our research into reality.

Our physician-scientists are constantly evaluating the latest medications for COPD patients as well as non-invasive surgical techniques to provide relief for their patients. We manage the effectiveness of new bronchiodialator medications for managing COPD symptoms.

Sidney Braman, MD, and David Yankelevitz, MD, are researching  chest imaging markers, based on analysis of CT scans of patients with COPD to predict acute exacerbations of COPD (AECOPD) and to characterize specific phenotypes among these COPD patients.

Drs. Juan Wisnivesky and Alex Federman are evaluating the association between health literacy and COPD self-management. In addition, our investigators participate in studies assessing cognitive decline among patients with COPD.

Gerry Turino, MD, Director of Lung Research at Mount Sinai St. Luke’s and Professor of Medicine, Critical Care, and Sleep Medicine, a leading expert in COPD research, is advancing work on COPD biomarker development and treatment strategies.